NCT02913885

Brief Summary

The aim of this study is to compare the effect of color change between remineralizing agent and guided enamel regeneration in treatment of white spot lesion after orthodontic treatments

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jan 2017

Shorter than P25 for phase_2

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 26, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

September 26, 2016

Status Verified

September 1, 2016

Enrollment Period

6 months

First QC Date

September 21, 2016

Last Update Submit

September 23, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • change in patient satisfaction

    using visual analogue scale from 0-100 (0= not satisfied , 100= totally satisfied)

    before, after 3 and 6 months

Secondary Outcomes (1)

  • change in color shade

    before, after 3 and 6 months

Study Arms (2)

Group 2

ACTIVE COMPARATOR

curodont repair is a biomimetic regeneration scaffold for remineralization

Drug: Curodont RepairDrug: fluoride varnish

Group 1

EXPERIMENTAL

fluoride varnish inhibit progression of white spot lesion

Drug: Curodont RepairDrug: fluoride varnish

Interventions

composed of biomimetic regeneration scaffold self-assembling peptides (P11-4) used for remineralization

Also known as: CURODONT™ REPAIR,Credentis, Switzerland
Group 1Group 2

fluoride inhibit the progression of white spot lesion

Also known as: 2.26% F, Duraphat, WoelmPharma GmbH, Germany
Group 1Group 2

Eligibility Criteria

Age12 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • No systemic disease.
  • Has completed fixed orthodontic treatment, brackets debonded.
  • Has at least two teeth with white spot lesion.
  • Has received conventional periodontal therapy after orthodontic treatment.
  • Between the ages of 12 and 25 years of age

You may not qualify if:

  • presence of enamel hypoplasia or dental fluorosis.
  • presence of tetracycline pigmentation.
  • periodontal pocketing of 3mm or greater.
  • taking antibiotics.
  • presence of carious cavities.
  • allergy to fluoride gel / varnish being used in study.
  • Subjects who had evidence of reduced salivary flow or significant tooth wear

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

sodium fluoride topical preparation

Central Study Contacts

aalaa M. Nabil, Master

CONTACT

rasha haridy, phD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer, conservative Dentistry Department MTI university

Study Record Dates

First Submitted

September 21, 2016

First Posted

September 26, 2016

Study Start

January 1, 2017

Primary Completion

July 1, 2017

Study Completion

September 1, 2017

Last Updated

September 26, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share